Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the
glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under
normal clinical practice conditions.